China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
000999
Classement en actions
#2914
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a prominent... China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a prominent pharmaceutical enterprise engaged in the research, development, manufacturing, and distribution of medicinal products. Its operations span both the People's Republic of China and international markets, additionally providing various health-related services. The company's extensive product line includes a wide range of over-the-counter (OTC) medications addressing common conditions such as colds, skin issues, gastrointestinal complaints, coughs, and needs in orthopedics and pediatrics. It also provides prescription drugs, with a focus on areas like traditional Chinese medicine, oncology, cardiovascular and cerebrovascular health, digestive system disorders, orthopedics, and pediatrics. Further offerings comprise Chinese medicine injections, specialized formula granules, and anti-infective agents. These products are often marketed under popular brand families, notably 999 family medicine, Sanjiuweitai series, 999 Ganmaoling series, and 999 dermatitis series. Founded in 1999 and headquartered in Shenzhen, PRC, the company initially operated as Sanjiu Pharmaceutical Co., Ltd. before rebranding to its current name in February 2010. It functions as a subsidiary under the umbrella of China Resources (Holdings) Co., Ltd.
Prix de l'action
$3.74
Capitalisation boursière
$6.23B
Changement (1 jour)
-2.11%
Changement (1 an)
-8.54%
Pays
CN
Échange China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999)
Catégorie
Healthcare
Revenus pour China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999)
Revenus en Jun 2026 TTM : $4.76B
Selon les derniers rapports financiers de China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., le chiffre d'affaires actuel de l'entreprise (TTM) est de $4.76B. En 2024, l'entreprise a réalisé un chiffre d'affaires de $3.78B une augmentation par rapport à le chiffre d'affaires de l'année 2023, qui était de $3.49B. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. de 2001 à 2026
Revenus à la fin de chaque année
| Année | Revenus | Changez |
|---|---|---|
| 2026 (TTM) | $4.76B | 5.44% |
| 2025 | $4.52B | 19.38% |
| 2024 | $3.78B | 8.26% |
| 2023 | $3.49B | 42.90% |
| 2022 | $2.45B | 17.16% |
| 2020 | $2.09B | -1.74% |
| 2019 | $2.12B | 8.83% |
| 2018 | $1.95B | 14.22% |
| 2017 | $1.71B | 32.12% |
| 2016 | $1.29B | 6.34% |
| 2015 | $1.22B | 3.56% |
| 2014 | $1.17B | -2.29% |
| 2013 | $1.20B | 7.98% |
| 2012 | $1.11B | 28.69% |
| 2011 | $865.22M | 30.83% |
| 2010 | $661.34M | -6.96% |
| 2009 | $710.79M | 12.37% |
| 2008 | $632.54M | 35.93% |
| 2007 | $465.35M | 26.67% |
| 2006 | $367.39M | -0.13% |
| 2005 | $367.88M | 23.67% |
| 2004 | $297.46M | -7.95% |
| 2003 | $323.17M | 23.51% |
| 2002 | $261.66M | 15.95% |
| 2001 | $225.66M | 0.00% |
Revenus d’entreprises similaires ou concurrentes
| Entreprise | Revenus | Différence de revenus | Pays |
|---|---|---|---|
| $23.54B | 394.15% |
DE
|
|
| $23.73B | 398.34% |
DE
|
|
| $29.24B | 513.92% |
JP
|
|
| $5.85B | 22.80% |
CH
|
|
| $6.34B | 33.16% |
IN
|
